Press Release

For Immediate Release
October 23, 2006

For more information, contact:
Mike Shefky at


Milwaukee---The International Society for Biological Therapy of Cancer (sitc) will showcase, explore, and critically evaluate the most promising advances in biological cancer therapies at its 21st Annual Meeting on October 26-29, at the Hyatt Regency Century Plaza in Los Angeles California.

This year's meeting features the second annual "Richard V. Smalley, MD Memorial Award and Lectureship" as well as an additional keynote address. As the 2006 "Smalley Award" winner, Ronald Levy, MD of the Stanford University School of Medicine will present "Checkpoint Blockade in Tumor Immunotherapy" on Friday, October 27. Lieping Chen, MD, PhD of the Johns Hopkins University School of Medicine will present "Lymphocyte Co-Signal Molecules in Cancer Immunotherapy" as the keynote address for Saturday, October 28.

21st Annual Meeting session topics include:

  • Adoptive Therapy
  • Antibodies
  • Cytokines
  • Dendritic Cells / Vaccines
  • Immune Monitoring
  • Immunoregulation / Costimulation
  • New Agents in Targeted Therapies
  • TLR / Innate Immunity

The 21st Annual Meeting will also have extended viewing times for over 130 scientific posters displayed by authors from around the world. Also, the ever-popular poster discussion session returns again this year. Our poster discussion sessions feature some of the year's best poster presentations and are led by top sitc Annual Meeting faculty members.

In conjunction with the Annual Meeting, the sitc is also holding two concurrent programs, the Primer on Tumor Immunology and Biological Therapy and the Mini-Symposium on Biologic Effects of Targeted Therapies, on Thursday, October 26. The Primer is a one-day general education program featuring a series of basic science, industry and clinical presentations related to the biological therapy of cancer. The Mini-Symposium is a half-day event with the purpose of publishing a "State of the Art" summary and a roadmap for how research in this specific field should proceed in the future.

On Saturday, October 28, the sitc will also announce its Presidential Award winner for 2006. The Presidential Award is presented to the author of the year's best abstract submitted by students, post doctoral fellows-in-training or Junior Faculty with three or less years on staff. Along with the award, the winner will receive a check for $1,000 from the sitc.

Founded in 1984, the International Society for Biological Therapy of Cancer (sitc) is an organization of clinicians, researchers, students, post-doctoral fellows, and allied health professionals dedicated to improving cancer patient outcomes by advancing the development and application of biological therapy through interaction, innovation and leadership.


EDITOR'S NOTE: Members of the media are encouraged to attend the 21st Annual Meeting free of charge by presenting their press credentials at the sitc Registration Desk located at the Hyatt Regency Century Plaza in Los Angeles, CA.